155 
† HR 5371 EAS 
FDA Food Safety Modernization Act (21 U.S.C. 2223), 
prior to July 20, 2028. Further, the U.S. Food and Drug 
Administration shall: 
(1) Engage quarterly with the regulated entities, 
including farms, restaurants, retail food establish-
ments, and warehouses distributing to retail food es-
tablishments and restaurants, to identify and imple-
ment, as appropriate, additional flexibilities for satis-
fying the rule’s lot-level tracking requirement, as ap-
propriate, such that regulated entities can comply 
with the November 21, 2022, rule consistent with sec-
tion 204(d)(1)(L)(iii), which prohibits the agency 
from requiring product tracking to the case level. 
(2) Within 180 days of enactment of this Act, the 
Food and Drug Administration is directed to provide 
industry stakeholders with recommendations for these 
additional flexibilities satisfying the rule’s lot-level 
tracking requirement, as appropriate. 
(3) The FDA shall provide assistance to industry 
regarding how to handle food waste recovery, reclama-
tion, intra-company transfers, customer returns under 
the rule and initiate a series of hypothetical data in-
take exercises to test the capabilities of the FDA’s 
Product Tracing System and, upon request and as re-
sources allow, the covered entity systems and identify
156 
† HR 5371 EAS 
any technical difficulties prior to full implementa-
tion. 
SEC. 781. Effective 365 days after the enactment of 
this Act, Section 297A of the Agricultural Marketing Act 
of 1946 (7 U.S.C. 1639o) is amended— 
(1) by redesignating paragraphs (2) through (6) 
as paragraphs (4) through (8), respectively; and 
(2) by striking paragraph (1) and inserting the 
following: 
‘‘(1) HEMP.— 
‘‘(A) IN GENERAL.—The term ‘hemp’ means 
the plant Cannabis sativa L. and any part of 
that plant, including the seeds thereof and all de-
rivatives, extracts, cannabinoids, isomers, acids, 
salts, and salts of isomers, whether growing or 
not, with a total tetrahydrocannabinols con-
centration 
(including 
tetrahydrocannabinolic 
acid) of not more than 0.3 percent on a dry 
weight basis. 
‘‘(B) INCLUSION.—Such term includes in-
dustrial hemp. 
‘‘(C) EXCLUSIONS.—Such term does not in-
clude— 
‘‘(i) any viable seeds from a Cannabis 
sativa L. plant that exceeds a total
157 
† HR 5371 EAS 
tetrahydrocannabinols concentration (in-
cluding tetrahydrocannabinolic acid) of 0.3 
percent in the plant on a dry weight basis; 
or 
‘‘(ii) any intermediate hemp-derived 
cannabinoid products containing— 
‘‘(I) cannabinoids that are not ca-
pable of being naturally produced by a 
Cannabis sativa L. plant; 
‘‘(II) cannabinoids that— 
‘‘(aa) are capable of being 
naturally produced by a Cannabis 
sativa L. plant; and 
‘‘(bb) were synthesized or 
manufactured outside the plant; 
or 
‘‘(III) more than 0.3 percent com-
bined total of— 
‘‘(aa) 
total 
tetrahydrocannabinols (including 
tetrahydrocannabinolic acid); and 
‘‘(bb) any other cannabinoids 
that have similar effects (or are 
marketed to have similar effects) 
on humans or animals as a
158 
† HR 5371 EAS 
tetrahydrocannabinol (as deter-
mined by the Secretary of Health 
and Human Services); or 
‘‘(iii) any intermediate hemp-derived 
cannabinoid products which are marketed 
or sold as a final product or directly to an 
end consumer for personal or household use; 
or 
‘‘(iv) 
any 
final 
hemp-derived 
cannabinoid products containing— 
‘‘(I) cannabinoids that are not ca-
pable of being naturally produced by a 
Cannabis sativa L. plant; 
‘‘(II) cannabinoids that— 
‘‘(aa) are capable of being 
naturally produced by a Cannabis 
sativa L. plant; and 
‘‘(bb) were synthesized or 
manufactured outside the plant; 
or 
‘‘(III) greater than 0.4 milligrams 
combined total per container of— 
‘‘(aa) 
total 
tetrahydrocannabinols (including 
tetrahydrocannabinolic acid); and
159 
† HR 5371 EAS 
‘‘(bb) any other cannabinoids 
that have similar effects (or are 
marketed to have similar effects) 
on humans or animals as a 
tetrahydrocannabinol (as deter-
mined by the Secretary of Health 
and Human Services). 
‘‘(2) INDUSTRIAL HEMP.—The term ‘industrial 
hemp’ means hemp— 
‘‘(A) grown for the use of the stalk of the 
plant, fiber produced from such a stalk, or any 
other non-cannabinoid derivative, mixture, prep-
aration, or manufacture of such a stalk; 
‘‘(B) grown for the use of the whole grain, 
oil, cake, nut, hull, or any other non- 
cannabinoid compound, derivative, mixture, 
preparation, or manufacture of the seeds of such 
plant; 
‘‘(C) grown for purposes of producing 
microgreens or other edible hemp leaf products 
intended for human consumption that are de-
rived from an immature hemp plant that is 
grown from seeds that do not exceed the threshold 
for total tetrahydrocannabinols concentration 
specified in paragraph (1)(C)(i);
160 
† HR 5371 EAS 
‘‘(D) that is a plant that does not enter the 
stream of commerce and is intended to support 
hemp research at an institution of higher edu-
cation (as defined in section 101 of the Higher 
Education Act of 1965 (20 U.S.C. 1001)) or an 
independent research institute; or 
‘‘(E) grown for the use of a viable seed of 
the plant produced solely for the production or 
manufacture of any material described in sub-
paragraphs (A) through (D). 
‘‘(3) HEMP-DERIVED CANNABINOID PRODUCT.— 
‘‘(A) IN GENERAL.—The term ‘hemp-derived 
cannabinoid product’ means any intermediate or 
final product derived from hemp (other than in-
dustrial hemp), that— 
‘‘(i) contains cannabinoids in any 
form; and 
‘‘(ii) is intended for human or animal 
use through any means of application or 
administration, such as inhalation, inges-
tion, or topical application. 
‘‘(B) The term ‘intermediate hemp-derived 
cannabinoid product’ means a hemp-derived 
cannabinoid product which—
161 
† HR 5371 EAS 
‘‘(i) is not yet in the final form or 
preparation marketed or intended to be used 
or consumed by a human or animal; or 
‘‘(ii) is a powder, liquid, tablet, oil, or 
other product form which is intended or 
marketed to be mixed, dissolved, formulated, 
or otherwise added to or prepared with or 
into any other substance prior to adminis-
tration or consumption. 
‘‘(C) The term ‘container’ means the inner-
most wrapping, packaging, or vessel in direct 
contact with a final hemp-derived cannabinoid 
product 
in 
which 
the 
final 
hemp-derived 
cannabinoid product is enclosed for retail sale to 
consumers, such as a jar, bottle, bag, box, packet, 
can, carton, or cartridge. 
‘‘(D) The term container excludes bulk ship-
ping containers or outer wrappings that are not 
essential for the final retail delivery or sale to an 
end consumer for personal or household use. 
‘‘(E) EXCLUSION.—Such term does not in-
clude a drug that is the subject of an application 
approved under subsection (c) or (j) of section 
505 of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 355).’’.
162 
† HR 5371 EAS 
(3) Within 90 days of the enactment of this act, 
the Food and Drug Administration, in consultation 
with other relevant Federal agencies, shall publish— 
(A) a list of all cannabinoids known to 
FDA to be capable of being naturally produced 
by a Cannabis sativa L. plant, as reflected in 
peer reviewed literature; 
(B) a list of all tetrahydrocannabinol class 
cannabinoids known to the agency to be natu-
rally occurring in the plant; 
(C) a list of all other know cannabinoids 
with similar effects to, or marketed to have simi-
lar 
effects 
to, 
tetrahyrocannabinol 
class 
cannabinoids; and 
(D) additional information and specificity 
about the term ‘‘container’’, as defined in para-
graph (3)(C). 
SEC. 782. In addition to amounts otherwise made 
available, there is hereby appropriated $2,000,000, to re-
main available until expended, for the Meat and Poultry 
Processing Expansion Program established pursuant to sec-
tion 1001(b)(4) of the American Rescue Plan Act of 2021 
(Public Law 117–2) to award grants to processors of 
invasive, wild-caught catfish.
163 
† HR 5371 EAS 
SEC. 783. (a) During the period beginning on the effec-
tive date of the final rule entitled ‘‘Food Labeling: Nutrient 
Content Claims; Definition of Term ‘Healthy’ ’’ published 
in the Federal Register by the Food and Drug Administra-
tion on December 27, 2024 (89 Fed. Reg. 106064 et seq.) 
and ending on the compliance date specified in such final 
rule (referred to in this section as the ‘‘compliance period’’), 
a manufacturer may also continue to comply with the re-
quirements in effect on the day before such effective date 
relating to an implied nutrient content claim of ‘‘healthy’’ 
made with respect to a food. 
(b) In the case of a food that bears labeling making 
an implied nutrition content claim that the food is 
‘‘healthy’’ during the compliance period, the manufacturer 
of the food shall not be directly or indirectly subject to any 
State law requirement relating to labeling making an im-
plied nutrient content claim that a food is ‘‘healthy’’ during 
such period that is not identical to either— 
(1) the Federal requirements for labeling to make 
an implied nutrition content claim that a food is 
‘‘healthy’’ that were in effect on the day before the ef-
fective date of such final rule; or 
(2) the updated Federal requirements specified in 
the final rule for such a claim.
164 
† HR 5371 EAS 
SEC. 784. Of the unobligated balances available in the 
Department of the Treasury, Treasury Forfeiture Fund, es-
tablished by section 9703 of title 31, United States Code, 
$350,000,000 shall be permanently rescinded not later than 
September 30, 2026. 
SEC. 785. The Commissioner of the Food and Drug 
Administration shall develop a report to determine the cost 
and any implications associated with efforts to issue a pro-
posed rule and implement FDA guidance and enforcement 
for setting standards for pet and animal food labeling and 
ingredient regulation: Provided, That the report shall— 
(1) cover intent for harmonization across state 
and Federal regulatory bodies for pet and animal 
food labeling and ingredients; 
(2) include timelines for developing guidelines, 
proposed regulations, resource and personnel needs to 
implement such standards, and where FDA would 
need additional authority to implement any proposed 
changes; and 
be submitted to the House and Senate Committees on Ap-
propriations within 120 days of enactment of this Act. 
SEC. 786. Any remaining unobligated balances from 
amounts made available by section 743 of division A of the 
Consolidated Appropriations Act, 2017 (Public Law 115– 
31) may be used, in addition to any funds otherwise made
165 
† HR 5371 EAS 
available for such purposes, for plans, construction, repair, 
preventive maintenance, environmental support, improve-
ment, extension, alteration, and purchase of fixed equip-
ment or facilities, as authorized by 7 U.S.C. 2250, and ac-
quisition of land as authorized by 7 U.S.C. 2268a. 
SEC. 787. For fiscal year 2026, the maximum monthly 
allowances of fluid milk for the following food packages de-
scribed in section 246.10(e) of title 7, Code of Federal Regu-
lations, are: 
(1) For Food Package IV, 16 quarts. 
(2) For Food Package V, 22 quarts. 
(3) For Food Package VI, 16 quarts. 
(4) For Food Package VII, 24 quarts. 
(5) For Food Package III, the maximum month-
ly allowances of fluid milk should conform to the 
changes made to food packages IV, V, VI, and VII in 
this section. 
SEC. 788. The Secretary of Agriculture shall— 
(1) conduct a study to determine the feasibility 
of applying the Buy American requirement (as de-
scribed in section 201.21(d) of title 7 of the Code of 
Federal Regulations (2022)) to the supplemental nu-
trition assistance program under the Food and Nutri-
tion Act of 2008, and the special supplemental nutri-
tion program as authorized by section 17 of the Child
166 
† HR 5371 EAS 
Nutrition Act of 1966 (42 U.S.C. 1786), including the 
impact applying such requirement would have on the 
agricultural economy of the United States; and 
(2) not later than 1 year after the date of enact-
ment of this Act, the Secretary shall submit the re-
sults of such study to the House and Senate Commit-
tees on Appropriations, the House Agriculture Com-
mittee, and the Senate Agriculture, Nutrition, and 
Forestry Committee. 
SEC. 789. (a) The Secretary shall prepare a report by 
account that details the status of all projects specified in 
the table titled ‘‘Community Project Funding/Congression-
ally Directed Spending’’ in the explanatory statements ac-
companying prior year Agriculture, Rural Development, 
Food and Drug Administration, and Related Agencies Ap-
propriations Acts, as described in section 4 in the matter 
preceding division A of such Acts: Provided, That such re-
port shall include a breakout showing the subset of projects 
for which funds have not yet been obligated, or for which 
funds have been deobligated, an explanation for each such 
project’s obligation status, the fiscal year in which funds 
were originally made available for such project, and the pe-
riod of availability of such funds. 
(b) The Secretary shall submit the report described in 
subsection (a) to the Committees on Appropriations of the
238 
† HR 5371 EAS 
section 2806 of title 10, United States Code, and Military 
Construction Authorization Acts, $481,832,000, to remain 
available until expended. 
DEPARTMENT OF DEFENSE BASE CLOSURE ACCOUNT 
For deposit into the Department of Defense Base Clo-
sure Account, established by section 2906(a) of the Defense 
Base Closure and Realignment Act of 1990 (10 U.S.C. 2687 
note), $465,161,000, to remain available until expended. 
FAMILY HOUSING CONSTRUCTION, ARMY 
For expenses of family housing for the Army for con-
struction, including acquisition, replacement, addition, ex-
pansion, extension, and alteration, as authorized by law, 
$228,558,000, to remain available until September 30, 
2030. 
FAMILY HOUSING OPERATION AND MAINTENANCE, ARMY 
For expenses of family housing for the Army for oper-
ation and maintenance, including debt payment, leasing, 
minor construction, principal and interest charges, and in-
surance premiums, as authorized by law, $388,418,000. 
FAMILY HOUSING CONSTRUCTION, NAVY AND MARINE 
CORPS 
For expenses of family housing for the Navy and Ma-
rine Corps for construction, including acquisition, replace-
ment, addition, expansion, extension, and alteration, as au-
251 
† HR 5371 EAS 
Senate, and the Subcommittee on Military Construction 
and Veterans Affairs of the Committee on Appropriations 
of the House of Representatives. 
SEC. 128. For an additional amount for the accounts 
and in the amounts specified for design for child develop-
ment centers, to remain available until September 30, 2030: 
‘‘Military Construction, Army’’, $5,000,000; 
‘‘Military Construction, 
Navy 
and 
Marine 
Corps’’, $5,000,000; and 
‘‘Military Construction, Air Force’’, $5,000,000: 
Provided, That not later than 60 days after the date of en-
actment of this Act, the Secretary of the military depart-
ment concerned, or their designee, shall submit to the Com-
mittees on Appropriations of both Houses of Congress an 
expenditure plan for funds provided under this section. 
SEC. 129. For an additional amount for the accounts 
and in the amounts specified for design for barracks, to re-
main available until September 30, 2030: 
‘‘Military Construction, Army’’, $5,000,000; 
‘‘Military Construction, 
Navy 
and 
Marine 
Corps’’, $5,000,000; and 
‘‘Military Construction, Air Force’’, $5,000,000: 
Provided, That not later than 60 days after the date of en-
actment of this Act, the Secretary of the military depart-
ment concerned, or their designee, shall submit to the Com-